Thermo Fisher seeks grant proposals that leverage NGS

By The Science Advisory Board staff writers

September 29, 2021 -- Thermo Fisher Scientific is accepting new proposals that leverage next-generation sequencing (NGS) for its Oncomine Clinical Research Grant.

The firm aims to fund clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. Recipients receive up to $200,000 in reagents and general funding.

Grant proposals can be submitted until October 25, 2021.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.